Skip to content

Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening

Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03945175
Acronym
MYDAYIS
Enrollment
52
Registered
2019-05-10
Start date
2020-07-15
Completion date
2022-05-11
Last updated
2024-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit-Hyperactivity

Brief summary

Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric disorder characterized by problems with sustaining attention, organization, planning, procrastination, daydreaming, restlessness, impulsivity and hyperactivity.This is an outpatient study for subjects between the ages of 18-60, who have an Attention deficit hyperactivity disorder (ADHD) diagnosis meeting all inclusion criteria and not meeting any of the exclusion criteria.

Detailed description

One purpose of this trial is to extend the evidence basis for Mydayis in adult ADHD to include efficacy with a clinical ADHD symptom measure validated for DSM-5 adult ADHD. Another purpose of this trial is to re-examine the clinical efficacy of Mydayis later in the day on ADHD symptoms; the data on ADHD symptoms via the TASS 1 (Spencer et al. 2008) is a decade old and has not been examined in subsequent trials.

Interventions

DRUGMYDAYIS

MYDAYIS treatment will be given at a minimum dose of 12.5mg/day and will increase in increments of 12.5mg, up to 37.5mg, based upon clinical response and tolerability.

DRUGPlacebo

During the two-week, placebo lead-in, all patients will receive 12.5mg of placebo at Visit 1 and Visit 2.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female between the ages of 18-60 of all races and ethnicity. * Meets DSM V-TR criteria for a primary diagnosis of ADHD (including predominantly inattentive presentation, or combined presentation) as diagnosed via the Adult ADHD Clinician Diagnostic Scale version 1.2 (ACDS v1.2)

Exclusion criteria

* Meets DSM V-TR criteria for a primary diagnosis of hyperactive-impulsive type ADHD as diagnosed via the ACDS v1.2. * Any other current psychiatric disorder, determined via the M.I.N.I, which requires pharmacotherapy treatment. * Current suicidal ideation or history of suicide attempts, based on the Columbia- Suicide Severity Rating Scale(C-SSRS) * Lifetime history of bipolar disorder or any psychotic disorder as per the M.I.N.I * Pregnant, breastfeeding or women planning to become pregnant. * Positive urine drug toxicology are excluded. * Any other reason that, in the opinion of the investigator, prevents the subject from participating in the study or compromise the subject safety.

Design outcomes

Primary

MeasureTime frameDescription
Adult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Placebo Lead-InWeek 2 (End of Placebo Lead-In)18-item questionnaire measuring aspects of ADHD in adults. Participants rank items on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total score is the sum of responses and ranges from 0 to 54; higher scores indicate greater severity of ADHD.
Adult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Mydayis TreatmentWeek 6 (End of Mydayis Treatment)18-item questionnaire measuring aspects of ADHD in adults. Participants rank items on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total score is the sum of responses and ranges from 0 to 54; higher scores indicate greater severity of ADHD.

Secondary

MeasureTime frameDescription
AISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-InWeek 2 (End of Placebo Lead-In)The HI symptom subscale comprises 9 items of the AISRS measuring hyperactive-impulsive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe HI symptoms.
AISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis TreatmentWeek 6 (End of Mydayis Treatment)The HI symptom subscale comprises 9 items of the AISRS measuring hyperactive-impulsive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe HI symptoms.
Clinical Global Impression-Severity (CGI-S) Scale Score at End of Placebo Lead-InWeek 2 (End of Placebo Lead-In)7-item questionnaire requiring a clinician to rate the severity of a patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. The ratings range from 1-7, where: 1 = Normal, not at all ill; 2 = Borderline mentally ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; and 7 = Among the most extremely ill patients.
Clinical Global Impression-Severity (CGI-S) Scale Score at End of Mydayis TreatmentWeek 6 (End of Mydayis Treatment)7-item questionnaire requiring a clinician to rate the severity of a patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. The ratings range from 1-7, where: 1 = Normal, not at all ill; 2 = Borderline mentally ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; and 7 = Among the most extremely ill patients.
14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Placebo Lead-InWeek 2 (End of Placebo Lead-In)18-item assessment of the severity of ADHD symptoms administered 14 hours after morning dosing. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total score is the sum of all the items on the scale and ranges from 0 to 54. A higher total score indicates more severe ADHD.
14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Mydayis TreatmentWeek 6 (End of Mydayis Treatment)18-item assessment of the severity of ADHD symptoms administered 14 hours after morning dosing. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total score is the sum of all the items on the scale and ranges from 0 to 54. A higher total score indicates more severe ADHD.
14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-InWeek 2 (End of Placebo Lead-In)The IA symptom subscale comprises 9 items of the TASS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe IA symptoms. Administered 14 hours after morning dosing.
14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Mydayis TreatmentWeek 6 (End of Mydayis Treatment)The IA symptom subscale comprises 9 items of the TASS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe IA symptoms. Administered 14 hours after morning dosing.
14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-InWeek 2 (End of Placebo Lead-In)The HI symptom subscale comprises 9 items of the TASS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe HI symptoms. Administered 14 hours after morning dosing.
14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis TreatmentWeek 6 (End of Mydayis Treatment)The HI symptom subscale comprises 9 items of the TASS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe HI symptoms. Administered 14 hours after morning dosing.
Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 3Week 375-item questionnaire measuring an adult's cognitive, emotional, and behavioral functions within the past month. Items ranked on 3-point Likert scale (1 = Never, 2 = Sometimes, 3 = Often). Raw scores are calculated and used to generate T-scores for 8 scales (Inhibit; Shift; Emotional Control; Initiate; Working Memory; Plan/Organize; Task Monitor; and Organization of Materials), 2 summary index scales (Behavioral Regulation Index and Metacognition Index), and 1 scale reflecting overall functioning (Global Executive Composite). T-scores range from 30 to 100, with scores ≥65 indicating clinical impairment.
Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 7Week 775-item questionnaire measuring an adult's cognitive, emotional, and behavioral functions within the past month. Items ranked on 3-point Likert scale (1 = Never, 2 = Sometimes, 3 = Often). Raw scores are calculated and used to generate T-scores for 8 scales (Inhibit; Shift; Emotional Control; Initiate; Working Memory; Plan/Organize; Task Monitor; and Organization of Materials), 2 summary index scales (Behavioral Regulation Index and Metacognition Index), and 1 scale reflecting overall functioning (Global Executive Composite). T-scores range from 30 to 100, with scores ≥65 indicating clinical impairment.
WebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the working memory capacity - recall span domain, participants complete forward digit span task and are assessed based on the maximum length of a sequence of visually presented digits able to be entered on a keypad in correct order. The total score is the maximum length of the sequence of digits.
WebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the working memory capacity - recall span domain, participants complete forward digit span task and are assessed based on the maximum length of a sequence of visually presented digits able to be entered on a keypad in correct order. The total score is the maximum length of the sequence of digits.
WebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the working memory capacity - working memory accuracy domain, participants complete a digit span task. Participants are assessed based on the total number of correct trials in the forward digit span task where each incremental span length has two trials- at least one of which needs to be recalled correctly to progress.
WebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the working memory capacity - working memory accuracy domain, participants complete a digit span task. Participants are assessed based on the total number of correct trials in the forward digit span task where each incremental span length has two trials- at least one of which needs to be recalled correctly to progress.
WebNeuro Neurocognitive Assessment - Attention and Concentration - Reaction Time at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - reaction time domain, participants complete a continuous performance test. Participants are assessed based on their reaction time to space-bar presses, averaged across all correctly identified target stimuli (same letter presented twice in a row).
WebNeuro Neurocognitive Assessment - Attention and Concentration - Reaction Time at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - reaction time domain, participants complete a continuous performance test. Participants are assessed based on their reaction time to space-bar presses, averaged across all correctly identified target stimuli (same letter presented twice in a row).
WebNeuro Neurocognitive Assessment - Attention and Concentration - False Alarms at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - false alarms domain, participants complete a continuous performance test. Participants are assessed based on the number of times the space-bar was pressed at any time not in response to a target stimulus.
WebNeuro Neurocognitive Assessment - Attention and Concentration - False Alarms at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - false alarms domain, participants complete a continuous performance test. Participants are assessed based on the number of times the space-bar was pressed at any time not in response to a target stimulus.
WebNeuro Neurocognitive Assessment - Attention and Concentration - False Misses at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - false misses domain, participants complete a continuous performance test. Participants are assessed based on the number of times when the space-bar was NOT pressed following a target stimulus.
WebNeuro Neurocognitive Assessment - Attention and Concentration - False Misses at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - false misses domain, participants complete a continuous performance test. Participants are assessed based on the number of times when the space-bar was NOT pressed following a target stimulus.
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Completion Time at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - completion time domain, participants complete a switching of attention task. Participants are assessed based on the total amount of time taken to complete the whole sequence of digits and letters.
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Completion Time at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - completion time domain, participants complete a switching of attention task. Participants are assessed based on the total amount of time taken to complete the whole sequence of digits and letters.
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Average Connection Time at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - average connection time domain, participants complete a switching of attention task. Participants are assessed based on the average time between correct responses.
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Average Connection Time at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - average connection time domain, participants complete a switching of attention task. Participants are assessed based on the average time between correct responses.
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors domain, participants complete a switching of attention task. Participants are assessed based on the number of times an incorrect digit or letter in the sequence was pressed.
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors domain, participants complete a switching of attention task. Participants are assessed based on the number of times an incorrect digit or letter in the sequence was pressed.
WebNeuro Neurocognitive Assessment - Response Speed - Number of Taps at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the response speed - number of taps domain, participants complete a motor tapping task. Participants are assessed based on the number of times they were able to tap the spacebar in 30 seconds with their dominant hand.
WebNeuro Neurocognitive Assessment - Response Speed - Number of Taps at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the response speed - number of taps domain, participants complete a motor tapping task. Participants are assessed based on the number of times they were able to tap the spacebar in 30 seconds with their dominant hand.
WebNeuro Neurocognitive Assessment - Response Speed - Tapping Variability at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the response speed - tapping variability domain, participants complete a motor tapping task. Participants are assessed based on the standard deviation of the time interval between taps on the space-bar for the dominant hand.
WebNeuro Neurocognitive Assessment - Response Speed - Tapping Variability at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the response speed - tapping variability domain, participants complete a motor tapping task. Participants are assessed based on the standard deviation of the time interval between taps on the space-bar for the dominant hand.
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time domain, participants complete a choice reaction time task. Participants are assessed based on the average time taken to press the left or right arrow to correspond with which circle (left or right) is highlighted in each trial.
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time domain, participants complete a choice reaction time task. Participants are assessed based on the average time taken to press the left or right arrow to correspond with which circle (left or right) is highlighted in each trial.
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Words) at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - score (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the number of stimuli for which the name of the color-word was correctly selected (ignoring the font-color of the word) in the time limit of 30 seconds (i.e., a higher score reflects greater speed).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Words) at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - score (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the number of stimuli for which the name of the color-word was correctly selected (ignoring the font-color of the word) in the time limit of 30 seconds (i.e., a higher score reflects greater speed).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Words) at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the number of stimuli for which the name of the color-word was incorrectly selected (ignoring the font-color of the word) in the time limit of 30 seconds (i.e., a higher score reflects more errors).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Words) at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the number of stimuli for which the name of the color-word was incorrectly selected (ignoring the font-color of the word) in the time limit of 30 seconds (i.e., a higher score reflects more errors).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Words) at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the average reaction time for the stimuli for which the name of the color-word was correctly selected (ignoring the font-color of the word).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Words) at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the average reaction time for the stimuli for which the name of the color-word was correctly selected (ignoring the font-color of the word).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Colors) at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - score (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the number of stimuli for which the font-color of the color-word was correctly selected (ignoring the name of the word) in the time limit of 30 seconds (i.e., a higher score reflects greater speed).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Colors) at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - score (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the number of stimuli for which the font-color of the color-word was correctly selected (ignoring the name of the word) in the time limit of 30 seconds (i.e., a higher score reflects greater speed).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Colors) at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the number of stimuli for which the font-color of the color-word was incorrectly selected (ignoring the name of the word) in the time limit of 30 seconds (i.e., a higher score reflects more errors).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Colors) at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the number of stimuli for which the font-color of the color-word was incorrectly selected (ignoring the name of the word) in the time limit of 30 seconds (i.e., a higher score reflects more errors).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Colors) at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the average reaction time for the stimuli for which the font-color of the color-word was correctly selected (ignoring the name of the word).
WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Colors) at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the average reaction time for the stimuli for which the font-color of the color-word was correctly selected (ignoring the name of the word).
WebNeuro Neurocognitive Assessment - Executive Function - Trials Completed at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - trials completed domain, participants complete a maze task. Participants are assessed based on the number of trials taken to successfully complete the maze without error twice consecutively.
WebNeuro Neurocognitive Assessment - Executive Function - Trials Completed at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - trials completed domain, participants complete a maze task. Participants are assessed based on the number of trials taken to successfully complete the maze without error twice consecutively.
WebNeuro Neurocognitive Assessment - Executive Function - Completion Time at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - completion time domain, participants complete a maze task. Participants are assessed based on the time taken to successfully complete the maze without error twice consecutively.
WebNeuro Neurocognitive Assessment - Executive Function - Completion Time at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - completion time domain, participants complete a maze task. Participants are assessed based on the time taken to successfully complete the maze without error twice consecutively.
WebNeuro Neurocognitive Assessment - Executive Function - Path Learning Time at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - path learning time domain, participants complete a maze task. Participants are assessed based on the time taken to the end of the final trial with at least one error- just before successfully completing the maze without error twice consecutively.
WebNeuro Neurocognitive Assessment - Executive Function - Path Learning Time at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - path learning time domain, participants complete a maze task. Participants are assessed based on the time taken to the end of the final trial with at least one error- just before successfully completing the maze without error twice consecutively.
WebNeuro Neurocognitive Assessment - Executive Function - Total Errors at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - total errors domain, participants complete a maze task. Participants are assessed based on the cumulative number of all types of errors made across all trials taken to complete the maze without error twice consecutively.
WebNeuro Neurocognitive Assessment - Executive Function - Total Errors at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - total errors domain, participants complete a maze task. Participants are assessed based on the cumulative number of all types of errors made across all trials taken to complete the maze without error twice consecutively.
WebNeuro Neurocognitive Assessment - Executive Function - Number of Overruns at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - number of overruns domain, participants complete a maze task. Participants are assessed based on the cumulative number of 'overrun' errors made across all trials taken to complete the maze without error twice consecutively. Overrun errors are specifically when subjects continue pressing in the same direction of movement through the maze instead of turning where required.
AISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-InWeek 2 (End of Placebo Lead-In)The IA symptom subscale comprises 9 items of the AISRS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe IA symptoms.
WebNeuro Neurocognitive Assessment - Impulsivity - Reaction Time at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - reaction time domain, participants complete a Go/No-Go task. Participants are assessed based on reaction time to spacebar press averaged across all correctly performed green press stimuli.
WebNeuro Neurocognitive Assessment - Impulsivity - Reaction Time at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - reaction time domain, participants complete a Go/No-Go task. Participants are assessed based on reaction time to spacebar press averaged across all correctly performed green press stimuli.
WebNeuro Neurocognitive Assessment - Impulsivity - False Alarms at BaselineBaselineWebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - false alarms domain, participants complete a Go/No-Go task. Participants are assessed based on the number of times when the spacebar was pressed at any time in response to a red don't press stimulus.
WebNeuro Neurocognitive Assessment - Impulsivity - False Alarms at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - false alarms domain, participants complete a Go/No-Go task. Participants are assessed based on the number of times when the spacebar was pressed a1t any time in response to a red don't press stimulus.
WebNeuro Neurocognitive Assessment - Impulsivity - False Misses at BaselineWeek 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - false misses domain, participants complete a Go/No-Go task. Participants are assessed based on the number of times when the spacebar was not pressed in response to a green press stimulus.
WebNeuro Neurocognitive Assessment - Impulsivity - False Misses at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - false misses domain, participants complete a Go/No-Go task. Participants are assessed based on the number of times when the spacebar was not pressed in response to a green press stimulus.
WebNeuro Neurocognitive Assessment - Executive Function - Number of Overruns at Week 7Week 7WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - number of overruns domain, participants complete a maze task. Participants are assessed based on the cumulative number of 'overrun' errors made across all trials taken to complete the maze without error twice consecutively. Overrun errors are specifically when subjects continue pressing in the same direction of movement through the maze instead of turning where required.
AISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Mydayis TreatmentWeek 6 (End of Mydayis Treatment)The IA symptom subscale comprises 9 items of the AISRS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe IA symptoms.

Countries

United States

Participant flow

Participants by arm

ArmCount
Placebo, Then Mydayis
After a two-week, single-blinded, placebo lead-in, all patients will receive four weeks of order-fixed treatment with Mydayis. MYDAYIS: MYDAYIS treatment will be given at a minimum dose of 12.5mg/day and will increase in increments of 12.5mg, up to 37.5mg, based upon clinical response and tolerability. Placebo: During the two-week, placebo lead-in, all patients will receive 12.5mg of placebo at Visit 1 and Visit 2.
20
Total20

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDid not meet inclusion criteria31
Overall StudyEarly termination during Mydayis treatment1
Overall StudyResponded to Placebo Treatment and was not Allocated to Mydayis1
Overall StudyWithdrew consent2

Baseline characteristics

CharacteristicPlacebo, Then Mydayis
Age, Continuous36.5 years
STANDARD_DEVIATION 10.27
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
17 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
7 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
12 Participants
Region of Enrollment
United States
20 participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 18
other
Total, other adverse events
14 / 18
serious
Total, serious adverse events
0 / 18

Outcome results

Primary

Adult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Mydayis Treatment

18-item questionnaire measuring aspects of ADHD in adults. Participants rank items on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total score is the sum of responses and ranges from 0 to 54; higher scores indicate greater severity of ADHD.

Time frame: Week 6 (End of Mydayis Treatment)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisAdult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Mydayis Treatment18.5 score on a scaleStandard Deviation 8.9
Primary

Adult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Placebo Lead-In

18-item questionnaire measuring aspects of ADHD in adults. Participants rank items on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total score is the sum of responses and ranges from 0 to 54; higher scores indicate greater severity of ADHD.

Time frame: Week 2 (End of Placebo Lead-In)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisAdult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Placebo Lead-In37.2 score on a scaleStandard Deviation 11.4
Secondary

14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis Treatment

The HI symptom subscale comprises 9 items of the TASS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe HI symptoms. Administered 14 hours after morning dosing.

Time frame: Week 6 (End of Mydayis Treatment)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then Mydayis14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis Treatment6.9 score on a scaleStandard Deviation 5.3
Secondary

14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-In

The HI symptom subscale comprises 9 items of the TASS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe HI symptoms. Administered 14 hours after morning dosing.

Time frame: Week 2 (End of Placebo Lead-In)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then Mydayis14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-In9.2 score on a scaleStandard Deviation 5.7
Secondary

14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Mydayis Treatment

The IA symptom subscale comprises 9 items of the TASS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe IA symptoms. Administered 14 hours after morning dosing.

Time frame: Week 6 (End of Mydayis Treatment)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then Mydayis14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Mydayis Treatment9.8 score on a scaleStandard Deviation 6.3
Secondary

14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-In

The IA symptom subscale comprises 9 items of the TASS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe IA symptoms. Administered 14 hours after morning dosing.

Time frame: Week 2 (End of Placebo Lead-In)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then Mydayis14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-In15.4 score on a scaleStandard Deviation 5.5
Secondary

14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Mydayis Treatment

18-item assessment of the severity of ADHD symptoms administered 14 hours after morning dosing. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total score is the sum of all the items on the scale and ranges from 0 to 54. A higher total score indicates more severe ADHD.

Time frame: Week 6 (End of Mydayis Treatment)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then Mydayis14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Mydayis Treatment16.8 score on a scaleStandard Deviation 10.8
Secondary

14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Placebo Lead-In

18-item assessment of the severity of ADHD symptoms administered 14 hours after morning dosing. Items are ranked on a 4-point Likert scale: 0 (not at all), 1 (mild), 2 (moderate), 3 (severe). The total score is the sum of all the items on the scale and ranges from 0 to 54. A higher total score indicates more severe ADHD.

Time frame: Week 2 (End of Placebo Lead-In)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then Mydayis14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Placebo Lead-In24.6 score on a scaleStandard Deviation 10.8
Secondary

AISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis Treatment

The HI symptom subscale comprises 9 items of the AISRS measuring hyperactive-impulsive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe HI symptoms.

Time frame: Week 6 (End of Mydayis Treatment)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisAISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis Treatment8.8 score on a scaleStandard Deviation 5
Secondary

AISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-In

The HI symptom subscale comprises 9 items of the AISRS measuring hyperactive-impulsive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe HI symptoms.

Time frame: Week 2 (End of Placebo Lead-In)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisAISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-In17.3 score on a scaleStandard Deviation 5.8
Secondary

AISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Mydayis Treatment

The IA symptom subscale comprises 9 items of the AISRS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe IA symptoms.

Time frame: Week 6 (End of Mydayis Treatment)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisAISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Mydayis Treatment9.6 score on a scaleStandard Deviation 4.7
Secondary

AISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-In

The IA symptom subscale comprises 9 items of the AISRS measuring inattentive symptoms of ADHD. Items are ranked on a 4-point Likert scale: 0 (none), 1 (mild), 2 (moderate), 3 (severe). The total IA subscale score ranges from 0 to 27; higher scores indicate more severe IA symptoms.

Time frame: Week 2 (End of Placebo Lead-In)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisAISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-In19.9 score on a scaleStandard Deviation 6.1
Secondary

Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 3

75-item questionnaire measuring an adult's cognitive, emotional, and behavioral functions within the past month. Items ranked on 3-point Likert scale (1 = Never, 2 = Sometimes, 3 = Often). Raw scores are calculated and used to generate T-scores for 8 scales (Inhibit; Shift; Emotional Control; Initiate; Working Memory; Plan/Organize; Task Monitor; and Organization of Materials), 2 summary index scales (Behavioral Regulation Index and Metacognition Index), and 1 scale reflecting overall functioning (Global Executive Composite). T-scores range from 30 to 100, with scores ≥65 indicating clinical impairment.

Time frame: Week 3

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisBehavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 368.6 T-scoreStandard Deviation 8.9
Secondary

Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 7

75-item questionnaire measuring an adult's cognitive, emotional, and behavioral functions within the past month. Items ranked on 3-point Likert scale (1 = Never, 2 = Sometimes, 3 = Often). Raw scores are calculated and used to generate T-scores for 8 scales (Inhibit; Shift; Emotional Control; Initiate; Working Memory; Plan/Organize; Task Monitor; and Organization of Materials), 2 summary index scales (Behavioral Regulation Index and Metacognition Index), and 1 scale reflecting overall functioning (Global Executive Composite). T-scores range from 30 to 100, with scores ≥65 indicating clinical impairment.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisBehavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 758.6 T-scoreStandard Deviation 14.9
Secondary

Clinical Global Impression-Severity (CGI-S) Scale Score at End of Mydayis Treatment

7-item questionnaire requiring a clinician to rate the severity of a patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. The ratings range from 1-7, where: 1 = Normal, not at all ill; 2 = Borderline mentally ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; and 7 = Among the most extremely ill patients.

Time frame: Week 6 (End of Mydayis Treatment)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisClinical Global Impression-Severity (CGI-S) Scale Score at End of Mydayis Treatment3.1 score on a scaleStandard Deviation 1
Secondary

Clinical Global Impression-Severity (CGI-S) Scale Score at End of Placebo Lead-In

7-item questionnaire requiring a clinician to rate the severity of a patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. The ratings range from 1-7, where: 1 = Normal, not at all ill; 2 = Borderline mentally ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; and 7 = Among the most extremely ill patients.

Time frame: Week 2 (End of Placebo Lead-In)

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisClinical Global Impression-Severity (CGI-S) Scale Score at End of Placebo Lead-In4.6 score on a scaleStandard Deviation 0.8
Secondary

WebNeuro Neurocognitive Assessment - Attention and Concentration - False Alarms at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - false alarms domain, participants complete a continuous performance test. Participants are assessed based on the number of times the space-bar was pressed at any time not in response to a target stimulus.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Attention and Concentration - False Alarms at Baseline1.3 Number of false alarmsStandard Deviation 1.2
Secondary

WebNeuro Neurocognitive Assessment - Attention and Concentration - False Alarms at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - false alarms domain, participants complete a continuous performance test. Participants are assessed based on the number of times the space-bar was pressed at any time not in response to a target stimulus.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Attention and Concentration - False Alarms at Week 71.0 Number of false alarmsStandard Deviation 1.3
Secondary

WebNeuro Neurocognitive Assessment - Attention and Concentration - False Misses at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - false misses domain, participants complete a continuous performance test. Participants are assessed based on the number of times when the space-bar was NOT pressed following a target stimulus.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Attention and Concentration - False Misses at Baseline0.7 Number of false missesStandard Deviation 0.9
Secondary

WebNeuro Neurocognitive Assessment - Attention and Concentration - False Misses at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - false misses domain, participants complete a continuous performance test. Participants are assessed based on the number of times when the space-bar was NOT pressed following a target stimulus.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Attention and Concentration - False Misses at Week 70.7 Number of false missesStandard Deviation 1
Secondary

WebNeuro Neurocognitive Assessment - Attention and Concentration - Reaction Time at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - reaction time domain, participants complete a continuous performance test. Participants are assessed based on their reaction time to space-bar presses, averaged across all correctly identified target stimuli (same letter presented twice in a row).

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Attention and Concentration - Reaction Time at Baseline567.0 millisecondsStandard Deviation 118
Secondary

WebNeuro Neurocognitive Assessment - Attention and Concentration - Reaction Time at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the attention and concentration - reaction time domain, participants complete a continuous performance test. Participants are assessed based on their reaction time to space-bar presses, averaged across all correctly identified target stimuli (same letter presented twice in a row).

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Attention and Concentration - Reaction Time at Week 7566.3 millisecondsStandard Deviation 145.4
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Completion Time at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - completion time domain, participants complete a maze task. Participants are assessed based on the time taken to successfully complete the maze without error twice consecutively.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Completion Time at Baseline234774.9 millisecondsStandard Deviation 87879.2
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Completion Time at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - completion time domain, participants complete a maze task. Participants are assessed based on the time taken to successfully complete the maze without error twice consecutively.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Completion Time at Week 7174054.1 millisecondsStandard Deviation 93675.1
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Number of Overruns at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - number of overruns domain, participants complete a maze task. Participants are assessed based on the cumulative number of 'overrun' errors made across all trials taken to complete the maze without error twice consecutively. Overrun errors are specifically when subjects continue pressing in the same direction of movement through the maze instead of turning where required.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Number of Overruns at Baseline14.8 Number of incorrect movesStandard Deviation 14.8
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Number of Overruns at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - number of overruns domain, participants complete a maze task. Participants are assessed based on the cumulative number of 'overrun' errors made across all trials taken to complete the maze without error twice consecutively. Overrun errors are specifically when subjects continue pressing in the same direction of movement through the maze instead of turning where required.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Number of Overruns at Week 712.8 Number of incorrect movesStandard Deviation 7.3
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Path Learning Time at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - path learning time domain, participants complete a maze task. Participants are assessed based on the time taken to the end of the final trial with at least one error- just before successfully completing the maze without error twice consecutively.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Path Learning Time at Baseline204859.7 millisecondsStandard Deviation 81156.1
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Path Learning Time at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - path learning time domain, participants complete a maze task. Participants are assessed based on the time taken to the end of the final trial with at least one error- just before successfully completing the maze without error twice consecutively.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Path Learning Time at Week 7148589.5 millisecondsStandard Deviation 88469
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Total Errors at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - total errors domain, participants complete a maze task. Participants are assessed based on the cumulative number of all types of errors made across all trials taken to complete the maze without error twice consecutively.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Total Errors at Baseline37.1 Number of incorrect movesStandard Deviation 27
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Total Errors at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - total errors domain, participants complete a maze task. Participants are assessed based on the cumulative number of all types of errors made across all trials taken to complete the maze without error twice consecutively.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Total Errors at Week 726.3 Number of incorrect movesStandard Deviation 13.1
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Trials Completed at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - trials completed domain, participants complete a maze task. Participants are assessed based on the number of trials taken to successfully complete the maze without error twice consecutively.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Trials Completed at Baseline9.5 Number of trials completedStandard Deviation 4.8
Secondary

WebNeuro Neurocognitive Assessment - Executive Function - Trials Completed at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the executive function - trials completed domain, participants complete a maze task. Participants are assessed based on the number of trials taken to successfully complete the maze without error twice consecutively.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Executive Function - Trials Completed at Week 78.1 Number of trials completedStandard Deviation 3.9
Secondary

WebNeuro Neurocognitive Assessment - Impulsivity - False Alarms at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - false alarms domain, participants complete a Go/No-Go task. Participants are assessed based on the number of times when the spacebar was pressed at any time in response to a red don't press stimulus.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Impulsivity - False Alarms at Baseline6.1 Number of spacebar pressesStandard Deviation 3.5
Secondary

WebNeuro Neurocognitive Assessment - Impulsivity - False Alarms at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - false alarms domain, participants complete a Go/No-Go task. Participants are assessed based on the number of times when the spacebar was pressed a1t any time in response to a red don't press stimulus.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Impulsivity - False Alarms at Week 75.2 Number of spacebar pressesStandard Deviation 3.6
Secondary

WebNeuro Neurocognitive Assessment - Impulsivity - False Misses at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - false misses domain, participants complete a Go/No-Go task. Participants are assessed based on the number of times when the spacebar was not pressed in response to a green press stimulus.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Impulsivity - False Misses at Baseline1.9 Number of spacebar pressesStandard Deviation 2
Secondary

WebNeuro Neurocognitive Assessment - Impulsivity - False Misses at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - false misses domain, participants complete a Go/No-Go task. Participants are assessed based on the number of times when the spacebar was not pressed in response to a green press stimulus.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Impulsivity - False Misses at Week 70.3 Number of spacebar pressesStandard Deviation 0.6
Secondary

WebNeuro Neurocognitive Assessment - Impulsivity - Reaction Time at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - reaction time domain, participants complete a Go/No-Go task. Participants are assessed based on reaction time to spacebar press averaged across all correctly performed green press stimuli.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Impulsivity - Reaction Time at Baseline308.2 millisecondsStandard Deviation 63.6
Secondary

WebNeuro Neurocognitive Assessment - Impulsivity - Reaction Time at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the impulsivity - reaction time domain, participants complete a Go/No-Go task. Participants are assessed based on reaction time to spacebar press averaged across all correctly performed green press stimuli.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Impulsivity - Reaction Time at Week 7307.8 millisecondsStandard Deviation 48.2
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Average Connection Time at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - average connection time domain, participants complete a switching of attention task. Participants are assessed based on the average time between correct responses.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Average Connection Time at Baseline2228.0 millisecondsStandard Deviation 617.3
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Average Connection Time at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - average connection time domain, participants complete a switching of attention task. Participants are assessed based on the average time between correct responses.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Average Connection Time at Week 71863.1 millisecondsStandard Deviation 517.9
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Completion Time at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - completion time domain, participants complete a switching of attention task. Participants are assessed based on the total amount of time taken to complete the whole sequence of digits and letters.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Completion Time at Baseline56771.9 millisecondsStandard Deviation 12548
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Completion Time at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - completion time domain, participants complete a switching of attention task. Participants are assessed based on the total amount of time taken to complete the whole sequence of digits and letters.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Completion Time at Week 747752.6 millisecondsStandard Deviation 12867.6
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors domain, participants complete a switching of attention task. Participants are assessed based on the number of times an incorrect digit or letter in the sequence was pressed.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors at Baseline0.8 Number of errorsStandard Deviation 1.2
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors domain, participants complete a switching of attention task. Participants are assessed based on the number of times an incorrect digit or letter in the sequence was pressed.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors at Week 70.7 Number of errorsStandard Deviation 0.7
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Colors) at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the number of stimuli for which the font-color of the color-word was incorrectly selected (ignoring the name of the word) in the time limit of 30 seconds (i.e., a higher score reflects more errors).

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Colors) at Baseline0.3 Number of incorrect trialsStandard Deviation 0.8
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Colors) at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the number of stimuli for which the font-color of the color-word was incorrectly selected (ignoring the name of the word) in the time limit of 30 seconds (i.e., a higher score reflects more errors).

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Colors) at Week 72.1 Number of incorrect trialsStandard Deviation 7
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Words) at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the number of stimuli for which the name of the color-word was incorrectly selected (ignoring the font-color of the word) in the time limit of 30 seconds (i.e., a higher score reflects more errors).

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Words) at Baseline0.2 Number of incorrect trialsStandard Deviation 0.8
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Words) at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - errors (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the number of stimuli for which the name of the color-word was incorrectly selected (ignoring the font-color of the word) in the time limit of 30 seconds (i.e., a higher score reflects more errors).

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Errors (Words) at Week 70.4 Number of incorrect trialsStandard Deviation 1.2
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time domain, participants complete a choice reaction time task. Participants are assessed based on the average time taken to press the left or right arrow to correspond with which circle (left or right) is highlighted in each trial.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time at Baseline379.2 millisecondsStandard Deviation 38.5
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time domain, participants complete a choice reaction time task. Participants are assessed based on the average time taken to press the left or right arrow to correspond with which circle (left or right) is highlighted in each trial.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time at Week 7378.2 millisecondsStandard Deviation 48.7
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Colors) at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the average reaction time for the stimuli for which the font-color of the color-word was correctly selected (ignoring the name of the word).

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Colors) at Baseline1526.8 millisecondsStandard Deviation 399.2
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Colors) at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the average reaction time for the stimuli for which the font-color of the color-word was correctly selected (ignoring the name of the word).

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Colors) at Week 71176.2 millisecondsStandard Deviation 263.7
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Words) at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the average reaction time for the stimuli for which the name of the color-word was correctly selected (ignoring the font-color of the word).

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Words) at Baseline1434.5 millisecondsStandard Deviation 961.6
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Words) at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - reaction time (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the average reaction time for the stimuli for which the name of the color-word was correctly selected (ignoring the font-color of the word).

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Reaction Time (Words) at Week 71248.4 millisecondsStandard Deviation 315.2
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Colors) at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - score (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the number of stimuli for which the font-color of the color-word was correctly selected (ignoring the name of the word) in the time limit of 30 seconds (i.e., a higher score reflects greater speed).

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Colors) at Baseline12.8 Number of correct trialsStandard Deviation 4.2
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Colors) at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - score (colors) domain, participants complete a verbal interference (color) task. Participants are assessed based on the number of stimuli for which the font-color of the color-word was correctly selected (ignoring the name of the word) in the time limit of 30 seconds (i.e., a higher score reflects greater speed).

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Colors) at Week 715.7 Number of correct trialsStandard Deviation 4.9
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Words) at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - score (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the number of stimuli for which the name of the color-word was correctly selected (ignoring the font-color of the word) in the time limit of 30 seconds (i.e., a higher score reflects greater speed).

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Words) at Baseline15.4 Number of correct trialsStandard Deviation 5.1
Secondary

WebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Words) at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the information processing efficiency - score (words) domain, participants complete a verbal interference (word) task. Participants are assessed based on the number of stimuli for which the name of the color-word was correctly selected (ignoring the font-color of the word) in the time limit of 30 seconds (i.e., a higher score reflects greater speed).

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Information Processing Efficiency - Score (Words) at Week 716.0 Number of correct trialsStandard Deviation 4
Secondary

WebNeuro Neurocognitive Assessment - Response Speed - Number of Taps at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the response speed - number of taps domain, participants complete a motor tapping task. Participants are assessed based on the number of times they were able to tap the spacebar in 30 seconds with their dominant hand.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Response Speed - Number of Taps at Baseline189.6 Number of tapsStandard Deviation 22.2
Secondary

WebNeuro Neurocognitive Assessment - Response Speed - Number of Taps at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the response speed - number of taps domain, participants complete a motor tapping task. Participants are assessed based on the number of times they were able to tap the spacebar in 30 seconds with their dominant hand.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Response Speed - Number of Taps at Week 7189.9 Number of tapsStandard Deviation 20
Secondary

WebNeuro Neurocognitive Assessment - Response Speed - Tapping Variability at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the response speed - tapping variability domain, participants complete a motor tapping task. Participants are assessed based on the standard deviation of the time interval between taps on the space-bar for the dominant hand.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Response Speed - Tapping Variability at Baseline24.4 millisecondsStandard Deviation 7.8
Secondary

WebNeuro Neurocognitive Assessment - Response Speed - Tapping Variability at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the response speed - tapping variability domain, participants complete a motor tapping task. Participants are assessed based on the standard deviation of the time interval between taps on the space-bar for the dominant hand.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Response Speed - Tapping Variability at Week 730.4 millisecondsStandard Deviation 24.2
Secondary

WebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the working memory capacity - recall span domain, participants complete forward digit span task and are assessed based on the maximum length of a sequence of visually presented digits able to be entered on a keypad in correct order. The total score is the maximum length of the sequence of digits.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at Baseline5.8 digitsStandard Deviation 2
Secondary

WebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the working memory capacity - recall span domain, participants complete forward digit span task and are assessed based on the maximum length of a sequence of visually presented digits able to be entered on a keypad in correct order. The total score is the maximum length of the sequence of digits.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at Week 76.4 score on a scaleStandard Deviation 1.2
Secondary

WebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at Baseline

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the working memory capacity - working memory accuracy domain, participants complete a digit span task. Participants are assessed based on the total number of correct trials in the forward digit span task where each incremental span length has two trials- at least one of which needs to be recalled correctly to progress.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at Baseline6.9 trials correctStandard Deviation 3.2
Secondary

WebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at Week 7

WebNeuro is a web-based computerized battery of several domains of neurocognitive functioning. In the working memory capacity - working memory accuracy domain, participants complete a digit span task. Participants are assessed based on the total number of correct trials in the forward digit span task where each incremental span length has two trials- at least one of which needs to be recalled correctly to progress.

Time frame: Week 7

ArmMeasureValue (MEAN)Dispersion
Placebo, Then MydayisWebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at Week 77.7 trials correctStandard Deviation 2.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026